Search Results

Alogliptin Use in Elderly People: A Pooled Analysis from Phase 2 and 3 Studies

Authors: Pratley, Richard E.; McCall, Thérèse; Fleck, Penny R.; Wilson, Craig A.; Mekki, Qais

Source: Journal of the American Geriatrics Society, Volume 57, Number 11, November 2009 , pp. 2011-2019(9)

Publisher: Blackwell Publishing

Peroxisome proliferator-activated receptor γ agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells

Authors: Aouali, Nassera; Palissot, Valérie; El-Khoury, Victoria; Moussay, Etienne; Janji, Bassam; Pierson, Sandrine; Brons, Nicolaas H. C.; Kellner, Laurent; Bosseler, Manon; Van Moer, Kris; Berchem, Guy

Source: British Journal of Haematology, Volume 147, Number 5, December 2009 , pp. 662-671(10)

Publisher: Blackwell Publishing

Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes

Authors: Derosa, G.; Tinelli, C.; Maffioli, P.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 12, December 2009 , pp. 1091-1099(9)

Publisher: Blackwell Publishing

CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone

Author: John Betteridge, D.

Source: Fundamental & Clinical Pharmacology, Volume 23, Number 6, December 2009 , pp. 675-679(5)

Publisher: Blackwell Publishing

The Role of Human CYP2C8 and CYP2C9 Variants in Pioglitazone Metabolism In Vitro

Authors: Muschler, Eugen; Lal, Jawahar; Jetter, Alexander; Rattay, Anke; Zanger, Ulrich; Zadoyan, Gregor; Fuhr, Uwe; Kirchheiner, Julia

Source: Basic & Clinical Pharmacology & Toxicology, Volume 105, Number 6, December 2009 , pp. 374-379(6)

Publisher: Blackwell Publishing

Weekly exenatide demonstrates QOL superiority in T2DM

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 589, 2009-10-17 , pp. 10-10(1)

Publisher: Adis International

Increased CV risk with rosiglitazone but not pioglitazone

Source: Reactions, Volume 1, Number 1276, 2009-10-31 , pp. 2-2(1)

Publisher: Adis International

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study*

Authors: Pratley, Richard E.; Reusch, Jane E.-B.; Fleck, Penny R.; Wilson, Craig A.; Mekki, Qais

Source: Current Medical Research and Opinion, Volume 25, Number 10, October 2009 , pp. 2361-2371(11)

Publisher: Informa Healthcare

Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17)

Authors: Scheen, A. J.; Tan, M. H.; Betteridge, D. J.; Birkeland, K.; Schmitz, O.; Charbonnel, B.

Source: Diabetic Medicine, Volume 26, Number 10, October 2009 , pp. 1033-1039(7)

Publisher: Blackwell Publishing

Baseline differences in A1C explain apparent differences in efficacy of sitagliptin, rosiglitazone and pioglitazone

Authors: Chapell, R.; Gould, A. L.; Alexander, C. M.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 11, November 2009 , pp. 1009-1016(8)

Publisher: Blackwell Publishing

Gene-Activators Prevent and Regress Atherosclerosis and Reduce Mortality

Author: Luoma, Pauli V.

Source: Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Volume 7, Number 4, October 2009 , pp. 295-304(10)

Publisher: Bentham Science Publishers

Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment

Authors: Glintborg, Dorte; Andersen, Marianne; Richelsen, Bjørn; Bruun, Jens M.

Source: Clinical Endocrinology, Volume 71, Number 5, November 2009 , pp. 652-658(7)

Publisher: Blackwell Publishing

Exploring mechanism of pioglitazone-induced memory restorative effect in experimental dementia

Authors: Kaur, Baljinder; Singh, Nirmal; Jaggi, Amteshwar Singh

Source: Fundamental & Clinical Pharmacology, Volume 23, Number 5, October 2009 , pp. 557-566(10)

Publisher: Blackwell Publishing

Emerging Treatments in Cystic Fibrosis

Authors: Jones, Andrew M.; Helm, Jennifer M.

Source: Drugs, Volume 69, Number 14, 1 October 2009 , pp. 1903-1910(8)

Publisher: Adis International

Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months

Authors: Ibáñez, Lourdes; López-Bermejo, Abel; Díaz, Marta; Enríquez, Goya; del Río, Luis; de Zegher, Francis

Source: Clinical Endocrinology, Volume 71, Number 3, September 2009 , pp. 351-357(7)

Publisher: Blackwell Publishing

Peroxisome proliferator-activated receptor γ (PPAR) agonism reduces the insulin-stimulated increase in circulating interleukin-6 in GH replaced GH-deficient adults

Authors: Krag, Morten B.; Rasmussen, Lars M.; Hansen, Troels K.; Frystyk, Jan; Flyvbjerg, Allan; Møller, Niels; Jørgensen, Jens O. L.

Source: Clinical Endocrinology, Volume 71, Number 3, September 2009 , pp. 363-368(6)

Publisher: Blackwell Publishing

Oral Antidiabetic Agents: Anti-Atherosclerotic Properties Beyond Glucose Lowering?

Authors: Papanas, N.; Maltezos, E.

Source: Current Pharmaceutical Design, Volume 15, Number 27, September 2009 , pp. 3179-3192(14)

Publisher: Bentham Science Publishers

Targeting the Tumor Stroma with Peroxisome Proliferator Activated Receptor (PPAR) Agonists

Authors: Bundscherer, Annika; Reichle, Albrecht; Hafner, Christian; Meyer, Stefanie; Vogt, Thomas

Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry, Volume 9, Number 7, September 2009 , pp. 816-821(6)

Publisher: Bentham Science Publishers

Pioglitazone: First report of rhabdomyolysis: case report

Source: Reactions, Volume 1, Number 1266, 2009-08-22 , pp. 25-25(1)

Publisher: Adis International

Earlier triple therapy with pioglitazone in patients with type 2 diabetes

Authors: Charpentier, G.; Halimi, S.

Source: Diabetes, Obesity and Metabolism, Volume 11, Number 9, September 2009 , pp. 844-854(11)

Publisher: Blackwell Publishing